Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+67.7%
5Y CAGR+32.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+67.7%/yr
vs -12.6%/yr prior
5Y CAGR
+32.2%/yr
Recent acceleration
Acceleration
+80.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $172.41M | +89.7% |
| 2024 | $90.89M | +117.7% |
| 2023 | $41.76M | +14.3% |
| 2022 | $36.53M | -27.6% |
| 2021 | $50.47M | +18.3% |
| 2020 | $42.65M | +83.7% |
| 2019 | $23.21M | -62.8% |
| 2018 | $62.46M | +16.3% |
| 2017 | $53.69M | -5.7% |
| 2016 | $56.91M | - |